Merck plummets as drug pulled
320680
Pharmaceutical titan Merck &amp; Co. Inc. yesterday pulled its blockbuster arthritis drug Vioxx off the market, citing safety concerns, thereby triggering a massive selloff in the company&#39;s shares that wiped out nearly US$27-billion of Merck&#39;s market value.
605604
WHITEHOUSE STATION, NJ - Shares of Merck &amp; Co. plunged almost 9 percent Monday after a media report said that documents show the pharmaceutical giant hid or denied evidence for years that its blockbuster arthritis drug Vioxx cause heart problems.
122550
The Dow Jones Industrial Average dropped after Merck &amp; Co. withdrew the Vioxx painkiller and retracted its third-quarter profit forecast.
380561
Shares of Merck &amp; Co. plunged almost 10 percent yesterday after a media report said that documents show the pharmaceutical giant hid or denied
364643
Merck &amp; Co Inc. on Thursday pulled its arthritis drug Vioxx off the market after a study showed it doubled the risk of heart attack and stroke, a move that sent its
57265
Merck &amp; Co.&#39;s decision to pull its Vioxx anti-arthritis drug from the markets due to severe side effects left pharmaceutical sector mixed Thursday.
150871
Merck (MRK) said Thursday that it is withdrawing its arthritis drug Vioxx globally following indications that the drug raises the risk of heart attack and stroke.
497670
Oct. 11 issue - Last week Merck pulled its blockbuster arthritis-and-pain-relief drug Vioxx from the market. This week the 1.27 million Americans who were taking it are wondering what to do.
537750
US blue chips fell on Thursday after drug company Merck &amp; Co.(MRK.N: Quote, Profile, Research) said it was withdrawing its key arthritis drug Vioxx, while relentless oil prices floated back to $50 a barrel.
627734
Merck &amp; Co. Inc. (MRK.N: Quote, Profile, Research) , whose shares have tumbled since the withdrawal of its blockbuster arthritis drug Vioxx, said on Monday it has adopted a severance benefits
506626
Merck pulled Vioxx from the market on September 30th, saying it was acting in the best interest of patients. But internal documents reportedly show the company knew as far back as 2000 that
574875
NEW YORK - Merck suffered a huge blow last week when it had to pull its blockbuster painkiller Vioxx from the market after a big study showed that it doubled the risk of heart attacks and strokes.
704632
NEW YORK, Sept. 30 -- Wall Street closed out a dismal third quarter with a mixed performance Thursday after Merck said it would be forced to remove its best-selling Vioxx arthritis drug from the market. Merck's unexpected bad news left blue chips with a loss for the day, while high-tech stocks got a lift from bargain hunters.
769773
TRENTON, N.J. -- Shares of drug maker Merck &amp; Co. dropped 2.5 percent in heavy trading yesterday, a day after medical journal reports offered fresh ammunition to patients suing over its withdrawn painkiller Vioxx.
408847
Merck posted a $1.63 billion fourth-quarter loss on Wednesday as  charges for its Vioxx litigation settlement dragged down results and share prices.
433075
When pharmaceutical giant Merck &amp; Co. abruptly pulled its arthritis pain medication Vioxx from the marketplace on Sept. 30, more than 2 million patients were taking the drug.
467183
NEW YORK - Investors sent stocks mostly lower Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market due to serious health risks...